search
Back to results

Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study) (PABLOS)

Primary Purpose

Pain, Postoperative, Cardiac Surgery

Status
Not yet recruiting
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
LRA Loco-regional anesthesia
Standardized post-operative analgesia protocol
Sponsored by
University Hospital, Angers
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Postoperative focused on measuring LRA, Block, ERAS, FQOR-15, QOR-15, Transversus thoracic block, Parasternal block, Cardiac surgery, Analgesia, PIP (parasternal intercostal plane block), Régional anesthesia

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Pre-inclusion criteria :

  • Adult patient (≥18 years old);
  • Patient having scheduled cardiac surgery with a sternotomy performed at the CHU d'Angers;
  • Patient having signed a consent;
  • French-speaking patient, able to understand and answer a questionnaire;
  • Affiliated patient or beneficiary of a social security scheme.

Criteria for confirming inclusion

  • Hemodynamic stability at the end of surgery;
  • Absence of bleeding justifying immediate revision surgery.

Non-inclusion criteria

  • Known hypersensitivity to amide-bonded local anesthetics;
  • Operation for cardiac revision surgery, including sternotomy REDUX (revision surgery);
  • Emergency surgery;
  • Surgery in a septic context (Endocarditis, Intravascular device infection);
  • Weight less than 30kg;
  • Severe psychiatric or cognitive impairment interfering with assessment by questionnaires;
  • Pregnant, breastfeeding or parturient woman;
  • Person deprived of liberty by judicial or administrative decision;
  • A person undergoing psychiatric treatment under duress;
  • Person subject to a measure of legal protection;
  • Inclusion in another interventional study modifying postoperative pain management.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Experimental

    Sham Comparator

    Arm Label

    TTP group (= Transversus Thoracic Plane block = Deep PIP = Deep parasternal intercostal plane block)

    PSB group (=ParaSternal Block = Superficial PIP = Superficial parasternal intercostal plane block)

    Control group

    Arm Description

    At the end of the surgery, realisation of a bilateral transverse thoracic block. (20ml of Naropeine 0.2%, each side) Followed by standard analgesic treatment.

    At the end of the surgery, realisation of a bilateral parasternal block (20ml of Naropeine 0.2%, each side). Followed by standard analgesic treatment.

    Standard analgesic treatment alone (without LRA) .

    Outcomes

    Primary Outcome Measures

    FQoR-15 score at 24 hours (French Quality of Recovery-15 score)
    Value of the French Quality of Recovery-15 score (minimum value of 0 and maximum value of 150, with a higher score for a better outcome). The QoR-15 questionnaires will be completed by the patient himself whenever possible, who could be helped by a nurse blinded to the assignment group.

    Secondary Outcome Measures

    Pain (VRS) at rest and mobilisation
    Analgesic efficacy at rest and during exercise (cough, physiotherapy session, mobilization) assessed via pain measurements by a simple verbal rating scale (VRS) with 11 items (0: no pain, 10: maximum pain)
    Post-operative consumption of morphine (milligrams)
    Amount of opioid consumption, in equivalent of milligrams.
    Post-operative consumption of daily non-morphine analgesics (milligrams)
    Including Pacetamol, Nefopam, ketoprofene, Ketamine in milligrams.
    Rate of painful patients
    Proportion of patients having had at least one VRS >3
    FQoR-15 score at 48 hours
    The quality of postoperative recovery reassessed 48 hours after surgery by the FQoR-15; Value of the French Quality of Recovery-15 score (minimum value of 0 and maximum value of 150, with a higher score for a better outcome). The QoR-15 questionnaires will be completed by the patient himself whenever possible, who could be helped by a nurse blinded to the assignment group.
    Rate of patients with at least one complication of LRA
    Proportion of patients with at least one complication of LRA: systemic intoxication with local anesthetics within 3 hours after injection, hematoma or infection at the puncture site.
    Rate of postoperative complications
    The proportion of patients with at least one major postoperative complication of cardiac surgery during hospitalization: de novo postoperative atrial fibrillation, revision surgery, respiratory failure, mediastinitis, neurological complication, acute renal failure, gastrointestinal complication, infectious complication with bacteremia, pneumothorax, infectious pneumonitis.
    Rate of patients return to preoperative weight
    Proportion of patient return to announced weight at the pre-anaesthetic consultation (truncating the weight in kg)
    Rate of patients return to a transit
    Proportion of patient return to a transit (including solid or gaseous transit)
    Extubation time (hours)
    Measured in number of hours since arrival in intensive care (between arrival in intensive care and the first attempt at extubation);
    Duration of hospitalization. (days)
    The length of stay in post-operative intensive care (between arrival in intensive care and leaving the service) and in the hospital counted in number of days started.
    Rate of readmission to intensive care.
    The proportion of patients admitted in the intensive care unit whatever the reason, censored at 30 days.

    Full Information

    First Posted
    April 12, 2022
    Last Updated
    April 25, 2022
    Sponsor
    University Hospital, Angers
    Collaborators
    Fondation Apicil
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05345639
    Brief Title
    Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study)
    Acronym
    PABLOS
    Official Title
    Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    July 1, 2022 (Anticipated)
    Primary Completion Date
    October 1, 2023 (Anticipated)
    Study Completion Date
    November 1, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University Hospital, Angers
    Collaborators
    Fondation Apicil

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The main objective is to compare the effectiveness of LocoRegional Anesthesia (LRA) (bilateral transverse thoracic block or bilateral parasternal block) in addition to standard management compared to standard management alone (general anesthesia without LRA) on the FQoR-15 (French Quality of Recovery - 15 score) at H+24 after cardiac surgery by sternotomy.This is a phase III monocentric superiority study , comparative, with three parallel groups, randomized with a ratio (1:1:1), controlled versus standard management, single-blind.
    Detailed Description
    Each year, more than one million patients worldwide undergo cardiac surgery via sternotomy. Postoperative pain is frequent in this context, affecting 49% of patients at rest and 78% during mobilization. This pain is associated with many avoidable post-operative complications. Nowadays, ERAS (Enhanced Rehabilitation After Surgery) protocols are increasingly developed in order to optimize post-operative rehabilitation. The management of postoperative pain is one of their main challenges and is based in particular on the use of locoregional anesthesia (LRA) with the aim of sparing morphine. Several LRAs have been described in cardiac surgery in recent years, and they are increasingly used in routine clinical practice. Transverse thoracic block and parasternal block are the main peripheral LRA techniques proposed for surgical procedures with sternotomy. Transverse chest block was first described in cardiac surgery in 2015 ; and the parasternal block in 2018. These techniques are spreading in current clinical practice because of their simplicity of implementation, their safety and their supposed effectiveness. The parasternal block is more recent, and presents a more superficial injection plane than the transverse thoracic block. Thus, it is theoretically as effective as the transverse thoracic and less at risk of complications. The main objective of this study is to compare the effectiveness of LRA (bilateral transverse thoracic block or bilateral parasternal block) in addition to standard management compared to standard management alone (general anesthesia without LRA) on the quality of early postoperative recovery after heart surgery by sternotomy. The primary endpoint is the postoperative recovery score in the French version, FQoR-15 (French Quality of Recovery - 15 score), performed at H+24. The FQoR-15 is currently one of the most reliable and reproducible tools for assessing the quality of postoperative rehabilitation. This instrument is one of the recommended endpoints for the evaluation of patient comfort, according to a recent consensus of international experts. This study is a phase III study of superiority, monocentric, comparative, with three parallel groups, randomized with a ratio (1:1:1), controlled versus standard care, single-blind. of inclusion is 254 patients included and randomized. The patient is pre-included during the pre-anaesthetic visit, the day before his scheduled surgery. He receives oral and written information, and provides his written consent to participate in this study, the follow-up will be 30 days. Depending on the randomization, the patient receives one of the following three treatments: bilateral transverse thoracic block followed by standard analgesic management; a bilateral parasternal block followed by standard analgesic treatment; standard analgesic treatment alone (without LRA). Bilateral parasternal block or transverse thoracic block are performed ultrasound-guided, at the end of surgery in the operating room. Once in the desired plane depending on the randomisation (transverse or parasternal), a volume of 20 ml of ropivacaine at 2 mg/ml is injected on each side of the sternum. The rest of the pain management is identical in the three groups according to the habits of the department. If the hypotheses on the effectiveness of parasternal block and/or transverse thoracic block are confirmed, postoperative recovery in the interventional arms will be improved. This will confirm the value of performing an LRA postoperatively.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pain, Postoperative, Cardiac Surgery
    Keywords
    LRA, Block, ERAS, FQOR-15, QOR-15, Transversus thoracic block, Parasternal block, Cardiac surgery, Analgesia, PIP (parasternal intercostal plane block), Régional anesthesia

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Model Description
    Study phase III, superiority study, monocentric, comparative, with three parallel groups, randomized with a ratio (1:1:1), controlled versus standard care, single-blind
    Masking
    Participant
    Masking Description
    Randomization takes place during surgery. Bilateral parasternal block or transverse thoracic block are performed ultrasound-guided, under general anesthesia.
    Allocation
    Randomized
    Enrollment
    280 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    TTP group (= Transversus Thoracic Plane block = Deep PIP = Deep parasternal intercostal plane block)
    Arm Type
    Experimental
    Arm Description
    At the end of the surgery, realisation of a bilateral transverse thoracic block. (20ml of Naropeine 0.2%, each side) Followed by standard analgesic treatment.
    Arm Title
    PSB group (=ParaSternal Block = Superficial PIP = Superficial parasternal intercostal plane block)
    Arm Type
    Experimental
    Arm Description
    At the end of the surgery, realisation of a bilateral parasternal block (20ml of Naropeine 0.2%, each side). Followed by standard analgesic treatment.
    Arm Title
    Control group
    Arm Type
    Sham Comparator
    Arm Description
    Standard analgesic treatment alone (without LRA) .
    Intervention Type
    Drug
    Intervention Name(s)
    LRA Loco-regional anesthesia
    Other Intervention Name(s)
    40ml Ropivacaine 0.2%
    Intervention Description
    Bilateral parasternal block or transverse thoracic block are performed ultrasound-guided, at the end of surgery in the operating room. Once in the desired plane depending on the randomisation (transverse or parasternal), a volume of 20 ml of ropivacaine at 2 mg/ml is injected on each side of the sternum. The intervention (TTP or PSB) is performed by the anesthetist-resuscitator investigator.
    Intervention Type
    Procedure
    Intervention Name(s)
    Standardized post-operative analgesia protocol
    Intervention Description
    The pain management protocol in intensive care is as follows: paracetamol 1g x 4 per day systematically (apart from the usual contraindications), IV then PO; PCA (Patient Controlled Analgesia) with oxycodone or morphine: 1mg bolus, 7min refractory period, maximum 4h dose 20mg. The PCA is usually maintained until 24-48h after the intervention then relayed by oxycodone 5mg every 4h if EVA > 3 sublingual and addition of oxycodone LP 10mg x 2 per day if daily intake on PCA > 20mg. Remedy molecules in case of ineffective analgesia: ketoprofen 100mg q12h IV, or 50mg q8h PO; nefopam 20mg every 6h IV or PO; ketamine 1 to 1.5 mg/kg/24H IVSE.
    Primary Outcome Measure Information:
    Title
    FQoR-15 score at 24 hours (French Quality of Recovery-15 score)
    Description
    Value of the French Quality of Recovery-15 score (minimum value of 0 and maximum value of 150, with a higher score for a better outcome). The QoR-15 questionnaires will be completed by the patient himself whenever possible, who could be helped by a nurse blinded to the assignment group.
    Time Frame
    24 hours after surgery
    Secondary Outcome Measure Information:
    Title
    Pain (VRS) at rest and mobilisation
    Description
    Analgesic efficacy at rest and during exercise (cough, physiotherapy session, mobilization) assessed via pain measurements by a simple verbal rating scale (VRS) with 11 items (0: no pain, 10: maximum pain)
    Time Frame
    3, 6, 12, 24, 48 , 72 hours after surgery and during the removal of surgical drains
    Title
    Post-operative consumption of morphine (milligrams)
    Description
    Amount of opioid consumption, in equivalent of milligrams.
    Time Frame
    3, 6, 12 hours after surgery and daily assessed at 24, 48, 72, 96 and 120 hours after surgery
    Title
    Post-operative consumption of daily non-morphine analgesics (milligrams)
    Description
    Including Pacetamol, Nefopam, ketoprofene, Ketamine in milligrams.
    Time Frame
    24, 48, 72, 96 and 120 hours after surgery
    Title
    Rate of painful patients
    Description
    Proportion of patients having had at least one VRS >3
    Time Frame
    24 and 48 hours after surgery
    Title
    FQoR-15 score at 48 hours
    Description
    The quality of postoperative recovery reassessed 48 hours after surgery by the FQoR-15; Value of the French Quality of Recovery-15 score (minimum value of 0 and maximum value of 150, with a higher score for a better outcome). The QoR-15 questionnaires will be completed by the patient himself whenever possible, who could be helped by a nurse blinded to the assignment group.
    Time Frame
    48 hours after surgery
    Title
    Rate of patients with at least one complication of LRA
    Description
    Proportion of patients with at least one complication of LRA: systemic intoxication with local anesthetics within 3 hours after injection, hematoma or infection at the puncture site.
    Time Frame
    30 days
    Title
    Rate of postoperative complications
    Description
    The proportion of patients with at least one major postoperative complication of cardiac surgery during hospitalization: de novo postoperative atrial fibrillation, revision surgery, respiratory failure, mediastinitis, neurological complication, acute renal failure, gastrointestinal complication, infectious complication with bacteremia, pneumothorax, infectious pneumonitis.
    Time Frame
    30 days
    Title
    Rate of patients return to preoperative weight
    Description
    Proportion of patient return to announced weight at the pre-anaesthetic consultation (truncating the weight in kg)
    Time Frame
    Noted at day 3 and 5 after surgery
    Title
    Rate of patients return to a transit
    Description
    Proportion of patient return to a transit (including solid or gaseous transit)
    Time Frame
    Noted at day 3 and 5 after surgery
    Title
    Extubation time (hours)
    Description
    Measured in number of hours since arrival in intensive care (between arrival in intensive care and the first attempt at extubation);
    Time Frame
    Noted at Day 30
    Title
    Duration of hospitalization. (days)
    Description
    The length of stay in post-operative intensive care (between arrival in intensive care and leaving the service) and in the hospital counted in number of days started.
    Time Frame
    Noted at Day 30
    Title
    Rate of readmission to intensive care.
    Description
    The proportion of patients admitted in the intensive care unit whatever the reason, censored at 30 days.
    Time Frame
    Noted at Day 30

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    100 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Pre-inclusion criteria : Adult patient (≥18 years old); Patient having scheduled cardiac surgery with a sternotomy performed at the CHU d'Angers; Patient having signed a consent; French-speaking patient, able to understand and answer a questionnaire; Affiliated patient or beneficiary of a social security scheme. Criteria for confirming inclusion Hemodynamic stability at the end of surgery; Absence of bleeding justifying immediate revision surgery. Non-inclusion criteria Known hypersensitivity to amide-bonded local anesthetics; Operation for cardiac revision surgery, including sternotomy REDUX (revision surgery); Emergency surgery; Surgery in a septic context (Endocarditis, Intravascular device infection); Weight less than 30kg; Severe psychiatric or cognitive impairment interfering with assessment by questionnaires; Pregnant, breastfeeding or parturient woman; Person deprived of liberty by judicial or administrative decision; A person undergoing psychiatric treatment under duress; Person subject to a measure of legal protection; Inclusion in another interventional study modifying postoperative pain management.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    JEANNETEAU Audrey, Dr
    Phone
    2 41 35 39 51
    Ext
    +33
    Email
    aujeanneteau@chu-angers.fr
    First Name & Middle Initial & Last Name or Official Title & Degree
    Unité de data-management DRCI - CHU Angers
    Phone
    2 41 35 58 46
    Ext
    +33

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    The data will be collected in a coded manner: 1st letter of the surname, 1st letter of the patient's first name, serial number of inclusion in the center by the physicians investigating the study in the electronic observation notebook of the study ( EnnovClinical) managed by the DRCI of the CHU of Angers.
    Citations:
    PubMed Identifier
    29027773
    Citation
    Bignami E, Castella A, Pota V, Saglietti F, Scognamiglio A, Trumello C, Pace MC, Allegri M. Perioperative pain management in cardiac surgery: a systematic review. Minerva Anestesiol. 2018 Apr;84(4):488-503. doi: 10.23736/S0375-9393.17.12142-5. Epub 2017 Oct 12.
    Results Reference
    background
    PubMed Identifier
    17006079
    Citation
    Lahtinen P, Kokki H, Hynynen M. Pain after cardiac surgery: a prospective cohort study of 1-year incidence and intensity. Anesthesiology. 2006 Oct;105(4):794-800. doi: 10.1097/00000542-200610000-00026.
    Results Reference
    background
    PubMed Identifier
    27343790
    Citation
    Huang AP, Sakata RK. Pain after sternotomy - review. Braz J Anesthesiol. 2016 Jul-Aug;66(4):395-401. doi: 10.1016/j.bjane.2014.09.013. Epub 2016 Apr 23.
    Results Reference
    background
    PubMed Identifier
    26658201
    Citation
    McIsaac DI, Cole ET, McCartney CJ. Impact of including regional anaesthesia in enhanced recovery protocols: a scoping review. Br J Anaesth. 2015 Dec;115 Suppl 2:ii46-56. doi: 10.1093/bja/aev376.
    Results Reference
    background
    PubMed Identifier
    26897453
    Citation
    Ueshima H, Hara E, Marui T, Otake H. RETRACTED: The ultrasound-guided transversus thoracic muscle plane block is effective for the median sternotomy. J Clin Anesth. 2016 Mar;29:83. doi: 10.1016/j.jclinane.2015.10.014. Epub 2016 Feb 9. No abstract available.
    Results Reference
    background
    PubMed Identifier
    24396082
    Citation
    de la Torre PA, Garcia PD, Alvarez SL, Miguel FJ, Perez MF. A novel ultrasound-guided block: a promising alternative for breast analgesia. Aesthet Surg J. 2014 Jan 1;34(1):198-200. doi: 10.1177/1090820X13515902. No abstract available.
    Results Reference
    background
    PubMed Identifier
    32654751
    Citation
    Leger M, Campfort M, Cayla C, Parot-Schinkel E, Lasocki S, Rineau E. Validation of an alternative French version of the Quality of Recovery-15 Score: the FQoR-15. Br J Anaesth. 2020 Oct;125(4):e345-e347. doi: 10.1016/j.bja.2020.05.052. Epub 2020 Jul 9. No abstract available.
    Results Reference
    background
    PubMed Identifier
    29397134
    Citation
    Kleif J, Waage J, Christensen KB, Gogenur I. Systematic review of the QoR-15 score, a patient- reported outcome measure measuring quality of recovery after surgery and anaesthesia. Br J Anaesth. 2018 Jan;120(1):28-36. doi: 10.1016/j.bja.2017.11.013. Epub 2017 Nov 22.
    Results Reference
    background
    PubMed Identifier
    29576111
    Citation
    Myles PS, Boney O, Botti M, Cyna AM, Gan TJ, Jensen MP, Kehlet H, Kurz A, De Oliveira GS Jr, Peyton P, Sessler DI, Tramer MR, Wu CL; StEP-COMPAC Group; Myles P, Grocott M, Biccard B, Blazeby J, Boney O, Chan M, Diouf E, Fleisher L, Kalkman C, Kurz A, Moonesinghe R, Wijeysundera D. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: patient comfort. Br J Anaesth. 2018 Apr;120(4):705-711. doi: 10.1016/j.bja.2017.12.037. Epub 2018 Feb 2.
    Results Reference
    background

    Learn more about this trial

    Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study)

    We'll reach out to this number within 24 hrs